glp 1 blue cross coverage Independence Cross, a major #insurance company, joins a growing number of firms not covering GLP-1 drugs for #weightloss, blaming exorbitant costs. Doctors say the drugs that treat diabetes and Blue Cross Blue Shield Drops

The letter emphasized several key points: Bulk compounding of semaglutide and tirzepatide is no longer permitted because FDA removed these products from the national shortage list Marketing terms such as generic Ozempic, semaglutide pills or vitamin-enhanced GLP-1 injections may violate state consumer-protection law when referring to non-approved formulations Misleading advertising of unapproved GLP-1 products falls under the Connecticut Unfair Trade Practices Act (CUTPA) Although the letter did not accuse any specific provider of wrongdoing, Connecticut placed clinics on formal notice that the GLP-1 market was under review and that enforcement would follow if risky practices continued

The real opportunity for our industry lies in not just how we meet that need, he says, but also how we use that technology responsibly and make it accessible to more people. For many people, the first wave of transformation was metabolic

GLP-1s for Diabetes: How They Help If you or someone you love has type 2 diabetes, GLP-1s might offer relief and control without the risks of older medications

The right combination depends on the condition being treated and the persons overall risk profile

MON-478 Increasing Prevalence of Obesity Through the First 5 Years of Life in Congenital Adrenal Hyperplasia